CT features of exophthalmos in Chinese subjects with thyroid-associated ophthalmopathy

被引:18
|
作者
Fang, Zhi-Jia [1 ]
Zhang, Jenny Y. [2 ]
He, Wei-Min [3 ]
机构
[1] Sichuan Univ, Dept Radiol, West China Hosp, Chengdu 610041, Sichuan Provinc, Peoples R China
[2] Univ Illinois, Chicago, IL 60607 USA
[3] Sichuan Univ, Dept Ophthalmol, West China Hosp, Chengdu 610041, Sichuan Provinc, Peoples R China
关键词
thyroid-associated ophthalmopathy (TAO); computed tomography (CT); exophthalmos; GRAVES OPHTHALMOPATHY; DISEASE-ACTIVITY; ORBITOPATHY; PREDICTION; MUSCLES; MRI;
D O I
10.3980/j.issn.2222-3959.2013.02.07
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
AIM: To investigate computed tomography (CT) features of exophthalmos in Chinese subjects with thyroid-associated ophthalmopathy (TAO). METHODS: A total of 605 eyes of 325 patients with exophthalmos due to TAO were classified as grade I (mild exophthalmos) or II (severe exophthalmos) based on orbital CT imaging. The increased orbital volume features, such as changes from extraocular muscles, orbital fat, or both, were analyzed. RESULTS: A total of 605 eyes were analyzed, among them 62.98% presented grade I exophthalmos, while 36.02% showed grade II exophthalmos. In grade I, 56.69% showed orbital fat change, and in grade II, 89.29% exhibited extraocular muscle enlargement. CONCLUSION: Orbital fat and extraocular muscle enlargement are likely to be observed on CTs of subjects with mild and severe exophthalmos, respectively. Our results suggest that CT findings may guide TAO clinical therapy recommendations and prognosis.
引用
收藏
页码:146 / 149
页数:4
相关论文
共 50 条
  • [21] Teprotumumab for Thyroid-Associated Ophthalmopathy
    Smith, Terry J.
    Kahaly, George J.
    Ezra, Daniel G.
    Fleming, James C.
    Dailey, Roger A.
    Tang, Rosa A.
    Harris, Gerald J.
    Antonelli, Alessandro
    Salvi, Mario
    Goldberg, Robert A.
    Gigantelli, James W.
    Couch, Steven M.
    Shriver, Erin M.
    Hayek, Brent R.
    Hink, Eric M.
    Woodward, Richard M.
    Gabriel, Kathleen
    Magni, Guido
    Douglas, Raymond S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (18): : 1748 - 1761
  • [22] Clinical features and clinical course of thyroid-associated ophthalmopathy: a case series of 3620 Chinese cases
    Du, Baixue
    Wang, Yujiao
    Yang, Mei
    He, Weimin
    EYE, 2021, 35 (08) : 2294 - 2301
  • [23] Clinical features and clinical course of thyroid-associated ophthalmopathy: a case series of 3620 Chinese cases
    Baixue Du
    Yujiao Wang
    Mei Yang
    Weimin He
    Eye, 2021, 35 : 2294 - 2301
  • [24] Thyroid-associated ophthalmopathy in patients with thyroid carcinoma
    Sun, Bin
    Zhang, Zhaoxia
    Ji, Xuan
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [25] RECOGNIZING AND TREATING THYROID-ASSOCIATED OPHTHALMOPATHY
    COLE, M
    MITCHELL, S
    PAISEY, R
    YELDHAM, D
    PRACTITIONER, 1995, 239 (1549) : 261 - 263
  • [26] 2021 update on thyroid-associated ophthalmopathy
    E. J. Neag
    T. J. Smith
    Journal of Endocrinological Investigation, 2022, 45 : 235 - 259
  • [27] Thyroid-associated ophthalmopathy: a new sign
    Gallenga, PE
    Mastropasqua, L
    Mancini, A
    Ciancaglini, M
    Zuppardi, E
    Lobefalo, L
    ULTRASONOGRAPHY IN OPHTHALMOLOGY XV, 1997, 61 : 371 - 376
  • [28] Ophthalmological evaluation in thyroid-associated ophthalmopathy
    Åsman, P
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 2003, 81 (05): : 437 - 448
  • [29] The Diagnosis and Treatment of Thyroid-Associated Ophthalmopathy
    Daniel J. Gould
    Forrest S. Roth
    Charles N. S. Soparkar
    Aesthetic Plastic Surgery, 2012, 36 : 638 - 648
  • [30] Teprotumumab Treatment for Thyroid-Associated Ophthalmopathy
    Smith, Terry J.
    EUROPEAN THYROID JOURNAL, 2020, 9 (SUPPL 1) : 31 - 39